Y-mAbs Therapeutics
Speed Read
0%
300 WPM
-- remaining
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody-based therapeutic products for the treatment of cancer, focusing on rare pediatric cancers and solid tumors.